title: Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
authors.affiliation: Department of Metabolic Diseases, Jagiellonian University, Medical College, 15 Kopernika St., 31-501 Krakow, Poland. mmalecki@cm-uj.krakow.pl
authors.forename: Maciej T
authors.initials: MT
authors.lastname: Malecki
authors.forename: Jan
authors.initials: J
authors.lastname: Skupien
authors.forename: Tomasz
authors.initials: T
authors.lastname: Klupa
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Wanic
authors.forename: Wojciech
authors.initials: W
authors.lastname: Mlynarski
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Gach
authors.forename: Iwona
authors.initials: I
authors.lastname: Solecka
authors.forename: Jacek
authors.initials: J
authors.lastname: Sieradzki
mesh_terms: D000328:Adult; D017668:Age of Onset; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D005786:Gene Expression Regulation; D006580:Genetic Carrier Screening; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000235:genetics*; D007328:Insulin / Q000097:blood / Q000627:therapeutic use; D008297:Male; D009154:Mutation; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D000099161:Kcnj11 Channel
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel